Bicycle Therapeutics Stock Market Value
| BCYC Stock | USD 20.54 0.28 1.38% |
| Symbol | Bicycle |
Bicycle Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.28) | Revenue Per Share 0.716 | Quarterly Revenue Growth (0.50) | Return On Assets (0.15) | Return On Equity (0.27) |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bicycle Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bicycle Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bicycle Therapeutics.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Bicycle Therapeutics on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Bicycle Therapeutics or generate 0.0% return on investment in Bicycle Therapeutics over 30 days. Bicycle Therapeutics is related to or competes with Ideaya Biosciences, AnaptysBio, MeiraGTx Holdings, Keros Therapeutics, Tenaya Therapeutics, IGM Biosciences, and Monte Rosa. Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that ar... More
Bicycle Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bicycle Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bicycle Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 35.92 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 4.68 |
Bicycle Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bicycle Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bicycle Therapeutics' standard deviation. In reality, there are many statistical measures that can use Bicycle Therapeutics historical prices to predict the future Bicycle Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bicycle Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bicycle Therapeutics Backtested Returns
Bicycle Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0134, which signifies that the company had a -0.0134% return per unit of standard deviation over the last 3 months. Bicycle Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bicycle Therapeutics' risk adjusted performance of (0.01), and Mean Deviation of 2.28 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.71, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bicycle Therapeutics will likely underperform. At this point, Bicycle Therapeutics has a negative expected return of -0.0595%. Please make sure to confirm Bicycle Therapeutics' standard deviation, kurtosis, relative strength index, as well as the relationship between the maximum drawdown and day median price , to decide if Bicycle Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Bicycle Therapeutics has good predictability. Overlapping area represents the amount of predictability between Bicycle Therapeutics time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bicycle Therapeutics price movement. The serial correlation of 0.72 indicates that around 72.0% of current Bicycle Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 2.78 |
Bicycle Therapeutics lagged returns against current returns
Autocorrelation, which is Bicycle Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bicycle Therapeutics' stock expected returns. We can calculate the autocorrelation of Bicycle Therapeutics returns to help us make a trade decision. For example, suppose you find that Bicycle Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bicycle Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bicycle Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bicycle Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bicycle Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Bicycle Therapeutics Lagged Returns
When evaluating Bicycle Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bicycle Therapeutics stock have on its future price. Bicycle Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bicycle Therapeutics autocorrelation shows the relationship between Bicycle Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Bicycle Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bicycle Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bicycle Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bicycle Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bicycle Therapeutics Stock:Check out Bicycle Therapeutics Correlation, Bicycle Therapeutics Volatility and Bicycle Therapeutics Alpha and Beta module to complement your research on Bicycle Therapeutics. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Bicycle Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.